Development of 166ho skin patch to treat skin diseases with 1 mw triga reactor.

摘要

sotopes from the lanthanide series are suitable for intense localized radiotherapy of tumors and melanomas. 166Ho is a promising radioisotope for use in medical radiotherapy due to its relatively short half-life of 26.8 hours and emission of high-energy beta -particles. 166Ho can be produced in suitable quantities using the USGS 1 MW TRIGA reactor located at the Denver Federal Center. A prototype patch was created by RF sputtering holmium oxide onto Kapton foil. The prototype patch showed that